Dr Reddy's Strategic Pivot Revitalises Indian Operations for FY26
Dr Reddy's Laboratories is making waves in the Indian pharmaceutical sector with a strategic overhaul aimed at boosting productivity and portfolio expansion. The launch of Obeda, a generic semaglutide injection, positions the company at the forefront of diabetes treatment in …
Read more →
